AstraZeneca’s defeat opens door to more challenges
June 24, 2005Sales and Marketing
Pharmaceutical companies found guilty of violating European antitrust laws can expect steeper fines than AstraZeneca, according to a leading law …
Side-effect doubts cloud future of Pargluva and Galida
June 24, 2005Sales and Marketing
A study comparing novel treatment Pargluva with a best-selling diabetes drug has yielded some positive results for the new drug, …
Acomplia filed in Europe and US
June 24, 2005Sales and Marketing
Sanofi-Aventis has submitted its new obesity treatment Acomplia to the European Union and US regulators.Even before its filing Acomplia (rimonabant) …
Novartis hails new MS pill as a breakthrough
June 23, 2005Sales and Marketing
Novartis says its new multiple sclerosis treatment is more effective than existing drugs in delaying the progress of the disease, …
Pfizer buys anti-infective specialists Vicuron
June 17, 2005Sales and Marketing
Pfizer has paid almost $2 billion for a US biopharmaceutical company with two promising anti-infective drugs.The acquisition of Vicuron Pharmaceuticals …
AZ fined E60 million by European Commission
June 16, 2005Sales and Marketing
AstraZeneca has been fined E60 million by the European Commission for illegally trying to extend the patent on its ulcer …
Bristol-Myers Squibb to limit direct to consumer advertising
June 15, 2005Medical Communications
Bristol-Myers Squibb has pledged to observe a stricter code of conduct in the promotion of its products to the public …
Older painkillers linked to heart attack risk
June 14, 2005Sales and Marketing
Two widely used painkillers ibuprofen and naproxen have been linked to increased rates of heart attacks in patients, a new …
BMS pays out $89 million in court settlement
June 14, 2005Sales and Marketing
Bristol-Myers Squibb has reached a deal to pay $89 million to settle four lawsuits related to inflated inventories and other …
Hepatitis B market to double by 2010
June 14, 2005Sales and Marketing
The hepatitis B market will double in size by 2010 and hit sales of $1 billion, according to analysts Datamonitor. …
The devil is in the detail
June 10, 2005Practice based commissioning looks set to have a major impact on how pharma companies organise their salesforces and promote and …
Does practice make perfect targeting?
June 3, 2005Sales and Marketing
Since the advent of brick sales information, numerous analytical techniques have become available to help identify the most valuable customers …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
